WRIGHT MEDICAL GROUP INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2014 12 months to Dec 31, 2014	FY2013 3 months to Mar 31, 2014	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Dec 31, 2010
Operating activities:
Net (loss) income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
Acquired in-process research and development costs
Amortization of intangible assets
Consolidated Depreciation
Stock-based compensation expense
Consolidated Intangible Amortization
Amortization of Financing Costs and Discounts
Deferred income taxes
Write off of deferred financing costs
Non-cash write-off of cumulative translation adjustment (CTA) balances
Excess tax benefit from stock-based compensation arrangements
Provision for losses on accounts receivable
Non-cash restructuring charges
Non Cash Adjustment Derivative Fair Value
Gain on Disposition of Intangible Assets
Gain On Previously Held Investment
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax
Goodwill and Intangible Asset Impairment
Other

Changes in assets and liabilities (net of acquisitions):
Accounts receivable
Inventories
Marketable securities
Prepaid expenses and other current assets
Accounts payable
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
Accrued expenses and other liabilities

Net cash provided by operating activities
Investing activities:
Capital expenditures
Acquisition of business
Purchase of intangible assets
Maturities of held-to-maturity marketable securities
Investment in held-to-maturity marketable securities
Sales and maturities of available-for-sale marketable securities
Investment in available-for-sale marketable securities
Other
Proceeds from sale of assets
Net cash used in investing activities

Financing activities:
Issuance of common stock
Financing under factoring agreement, net
Payments of long term borrowings
Proceeds from Issuance of Warrants
Payments for (Proceeds from) Hedge, Financing Activities
Redemption of convertible senior notes
Proceeds from long term borrowings
Payments of deferred financing costs
Payment of Financing and Stock Issuance Costs
Proceeds From Cash Settled Convertible Debt
Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax
Repayments of Long-term Capital Lease Obligations
Excess tax benefit from stock-based compensation arrangements
Net cash provided by (used in) financing activities

Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of year
Effect of exchange rates on cash and cash equivalents
Consolidated cash and cash equivalents, beginning of year
Consolidated Cash and Equivalents, end of year

Comments